amelparib (JPI-289) / Jeil  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amelparib (JPI-289) / Jeil
NCT01983358: The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

Completed
1
40
RoW
JPI-289, Placebo
Jeil Pharmaceutical Co., Ltd.
Stroke
08/14
09/14
NCT02396069: The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers

Completed
1
24
RoW
JPI-289, Placebo
Jeil Pharmaceutical Co., Ltd.
Stroke
08/15
08/15

Download Options